We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

585 hedge funds and large institutions have $2.19B invested in iShares US Medical Devices ETF in 2023 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 168 increasing their positions, 233 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 38

5% more funds holding

Funds holding: 557585 (+28)

0% more funds holding in top 10

Funds holding in top 10: 1515 (0)

4% less capital invested

Capital invested by funds: $2.28B → $2.19B (-$81.5M)

2.34% less ownership

Funds ownership: 38.08%35.74% (-2.3%)

28% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 233

32% less call options, than puts

Call options by funds: $12.4M | Put options by funds: $18.1M

Holders
585
Holders Change
+28
Holders Change %
+5.03%
% of All Funds
9.19%
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.24%
New
68
Increased
168
Reduced
233
Closed
38
Calls
$12.4M
Puts
$18.1M
Net Calls
-$5.71M
Net Calls Change
-$14M
Name Holding Trade Value Shares
Change
Change in
Stake
GVAG
251
Great Valley Advisor Group
Delaware
$832K +$14K +254 +2%
OIA
252
OneDigital Investment Advisors
Kansas
$823K -$314K -5,695 -28%
TC
253
TownSquare Capital
Utah
$815K +$51.1K +928 +7%
Brown Advisory
254
Brown Advisory
Maryland
$814K +$4.19K +76 +0.5%
Lido Advisors
255
Lido Advisors
California
$812K -$60K -1,090 -7%
BPA
256
Beacon Pointe Advisors
California
$808K +$134K +2,427 +20%
EWA
257
Exencial Wealth Advisors
Oklahoma
$804K -$5.04M -91,519 -87%
AIFAIM
258
American Institute for Advanced Investment Management
Arizona
$782K +$127K +2,305 +20%
GPA
259
Guerra Pan Advisors
New Jersey
$782K
VVP
260
Venture Visionary Partners
Ohio
$780K +$10K +182 +1%
GIA
261
Gladstone Institutional Advisory
Florida
$768K +$230K +4,172 +44%
ACM
262
AlphaStar Capital Management
North Carolina
$767K +$15K +273 +2%
BBA
263
BLB&B Advisors
Pennsylvania
$754K -$83.7K -1,520 -10%
GCM
264
Gallacher Capital Management
Colorado
$727K +$220 +4 +0%
ST
265
Spinnaker Trust
Maine
$726K
Carson Wealth (CWM LLC)
266
Carson Wealth (CWM LLC)
Nebraska
$724K +$18.9K +344 +3%
FWSM
267
First Wilshire Securities Management
California
$694K
LL
268
LWMG LLC
Minnesota
$693K -$9.42K -171 -1%
WG
269
Watchman Group
Texas
$688K -$41.3K -750 -6%
KDA
270
Kraft Davis & Associates
Missouri
$676K +$697K +12,658 New
RIA
271
Regal Investment Advisors
Michigan
$675K -$200K -3,632 -23%
LFAS
272
Level Four Advisory Services
Texas
$671K -$34.6K -629 -5%
GLA
273
Good Life Advisors
Pennsylvania
$667K -$37.3K -678 -5%
VNA
274
Valley National Advisers
Pennsylvania
$667K -$4.13K -75 -0.6%
SCA
275
Southern Capital Advisors
Tennessee
$664K +$647K +11,754 New

IHI Hedge Fund Activity: Q2 2023 in Review

585 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2023, worth a combined $2.19B — down 3.6% from $2.28B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new IHI positions and 38 closed out — a net gain of 30 holders — while 168 added to existing stakes and 233 trimmed.

The largest buyer was LPL Financial, adding an estimated $13.5M. The largest seller was Menora Mivtachim Holdings, exiting entirely with an estimated $107M sold.

  • 585 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2023, up from 557 in Q1 2023.
  • Funds reported $2.19B of iShares US Medical Devices ETF stock for Q2 2023, down 3.6% quarter-over-quarter.
  • 68 funds opened new iShares US Medical Devices ETF positions in Q2 2023 and 38 closed out, a net change of +30 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2023 was LPL Financial, an estimated $13.5M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2023 was Menora Mivtachim Holdings, an estimated $107M sold.

Based on aggregated 13F filings for Q2 2023.